{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:29Z","timestamp":1792787849380,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","award":["3010023"],"award-info":[{"award-number":["3010023"]}],"id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejphar.2021.174432","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T12:48:34Z","timestamp":1629204514000},"page":"174432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Trifluoperazine reduces cuprizone-induced demyelination via targeting Nrf2 and IKB in mice"],"prefix":"10.1016","volume":"909","author":[{"given":"Ehsan","family":"Khaledi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayebeh","family":"Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Mohammadi-Farani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8656-6838","authenticated-orcid":false,"given":"Antoni","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Yousefi-Manesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2790-2544","authenticated-orcid":false,"given":"Eduardo","family":"Sobarzo-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5000-3387","authenticated-orcid":false,"given":"Samira","family":"Shirooie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.ejphar.2021.174432_bib1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jneuroim.2013.06.012","article-title":"Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model","volume":"262","author":"Acs","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2021.174432_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1973834","article-title":"New insights into the role of oxidative stress mechanisms in the pathophysiology and treatment of multiple sclerosis","volume":"2016","author":"Adamczyk","year":"2016","journal-title":"Oxidative medicine and cellular longevity"},{"key":"10.1016\/j.ejphar.2021.174432_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jprot.2014.06.022","article-title":"Ca2+\u2013CaM regulating viability of Candida guilliermondii under oxidative stress by acting on detergent resistant membrane proteins","volume":"109","author":"An","year":"2014","journal-title":"Journal of proteomics"},{"key":"10.1016\/j.ejphar.2021.174432_bib4","series-title":"Advances in Multiple Sclerosis Research\u2013Series I","author":"Apostolopoulos","year":"2020"},{"key":"10.1016\/j.ejphar.2021.174432_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.appet.2020.104678","article-title":"The effect of the demyelinating agent cuprizone on binge-like eating of sweetened palatable food in female and male C57BL\/6 substrains","volume":"150","author":"Babbs","year":"2020","journal-title":"Appetite"},{"issue":"12","key":"10.1016\/j.ejphar.2021.174432_bib6","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1177\/1352458514567553","article-title":"Unilateral and bilateral upper limb dysfunction at body functions, activity and participation levels in people with multiple sclerosis","volume":"21","author":"Bertoni","year":"2015","journal-title":"Multiple Sclerosis Journal"},{"issue":"2","key":"10.1016\/j.ejphar.2021.174432_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00401-014-1310-2","article-title":"Macrophage subsets and microglia in multiple sclerosis","volume":"128","author":"Bogie","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.ejphar.2021.174432_bib8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.0000000000000768","article-title":"Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity","volume":"83","author":"Browne","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ejphar.2021.174432_bib9","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/nau.23101","article-title":"Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms","volume":"36","author":"Brucker","year":"2017","journal-title":"Neurourol. Urodyn."},{"issue":"7","key":"10.1016\/j.ejphar.2021.174432_bib10","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.apmr.2017.02.015","article-title":"Participation restriction in people with multiple sclerosis: prevalence and correlations with cognitive, walking, balance, and upper limb impairments","volume":"98","author":"Cattaneo","year":"2017","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"7","key":"10.1016\/j.ejphar.2021.174432_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/brainsci7070078","article-title":"Multiple sclerosis: immunopathology and treatment update","volume":"7","author":"Dargahi","year":"2017","journal-title":"Brain Sci."},{"issue":"11","key":"10.1016\/j.ejphar.2021.174432_bib12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0028-3908(94)90045-0","article-title":"Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures","volume":"33","author":"Dawson","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.174432_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2017.06.017","article-title":"Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients","volume":"811","author":"Delgado-Roche","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2021.174432_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41582-020-0355-1","article-title":"Treatment and management of cognitive dysfunction in patients with multiple sclerosis","volume":"16","author":"DeLuca","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174432_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep07002","article-title":"Neuroprotection by acetyl-11-keto-\u03b2-boswellic acid, in ischemic brain injury involves the Nrf2\/HO-1 defense pathway","volume":"4","author":"Ding","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174432_bib16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fimmu.2019.00705","article-title":"NF-\u03baB signaling in macrophages: dynamics, crosstalk, and signal integration","volume":"10","author":"Dorrington","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ejphar.2021.174432_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/gt.2014.33","article-title":"A comparative study of experimental mouse models of central nervous system demyelination","volume":"21","author":"Dumitrascu","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.ejphar.2021.174432_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.taap.2018.05.035","article-title":"Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: a pivotal role of AMPK\/SIRT1 and JAK2\/STAT3\/NF-\u03baB signalling pathway modulation","volume":"352","author":"Elbaz","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2021.174432_bib19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/hsz-2015-0295","article-title":"Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function","volume":"397","author":"Esteras","year":"2016","journal-title":"Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejphar.2021.174432_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.toxlet.2007.01.010","article-title":"Behavioral deficits in the cuprizone-induced murine model of demyelination\/remyelination","volume":"169","author":"Franco-Pons","year":"2007","journal-title":"Toxicol. Lett."},{"issue":"8","key":"10.1016\/j.ejphar.2021.174432_bib21","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bbadis.2013.12.011","article-title":"Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases","volume":"1842","author":"Gan","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.ejphar.2021.174432_bib22","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1007\/s12035-016-9891-5","article-title":"Resveratrol promotes remyelination in cuprizone model of multiple sclerosis: biochemical and histological study","volume":"54","author":"Ghaiad","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"14","key":"10.1016\/j.ejphar.2021.174432_bib23","doi-asserted-by":"crossref","first-page":"PL183","DOI":"10.1016\/S0024-3205(00)00447-1","article-title":"On the activity of trifluoperazine and palmitoylcarnitine in mice: delayed hypersensitivity models","volume":"66","author":"G\u00f3ngora","year":"2000","journal-title":"Life Sci."},{"issue":"14","key":"10.1016\/j.ejphar.2021.174432_bib24","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1177\/1352458516688349","article-title":"Hippocampal dysfunction is associated with memory impairment in multiple sclerosis: a volumetric and functional connectivity study","volume":"23","author":"Gonz\u00e1lez Torre","year":"2017","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.ejphar.2021.174432_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fncel.2014.00073","article-title":"Glial response during cuprizone-induced de-and remyelination in the CNS: lessons learned","volume":"8","author":"Gudi","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.ejphar.2021.174432_bib26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/BST20150011","article-title":"Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of \u03b2-TrCP and GSK-3","volume":"43","author":"Hayes","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejphar.2021.174432_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejphar.2017.02.044","article-title":"The novel Nrf2 inducer TFM-735 ameliorates experimental autoimmune encephalomyelitis in mice","volume":"802","author":"Higashi","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174432_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-2-53","article-title":"Complement activation in multiple sclerosis plaques: an immunohistochemical analysis","volume":"2","author":"Ingram","year":"2014","journal-title":"Acta neuropathologica communications"},{"issue":"6","key":"10.1016\/j.ejphar.2021.174432_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/a-1154-8672","article-title":"Trifluoperazine an antipsychotic drug and inhibitor of mitochondrial permeability transition protects cytarabine and ifosfamide-induced neurotoxicity","volume":"70","author":"Kiani","year":"2020","journal-title":"Drug Res."},{"issue":"12","key":"10.1016\/j.ejphar.2021.174432_bib30","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1161\/01.STR.28.12.2539","article-title":"The calmodulin antagonist trifluoperazine in transient focal brain ischemia in rats: anti-ischemic effect and therapeutic window","volume":"28","author":"Kuroda","year":"1997","journal-title":"Stroke"},{"issue":"6437","key":"10.1016\/j.ejphar.2021.174432_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/364535a0","article-title":"NMDA-dependent superoxide production and neurotoxicity","volume":"364","author":"Lafon-Cazal","year":"1993","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174432_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2522\/ptj.20130588","article-title":"Associations of upper limb disability measures on different levels of the International Classification of Functioning, Disability and Health in people with multiple sclerosis","volume":"95","author":"Lamers","year":"2015","journal-title":"Phys. Ther."},{"issue":"11","key":"10.1016\/j.ejphar.2021.174432_bib33","doi-asserted-by":"crossref","first-page":"22558","DOI":"10.3390\/ijms141122558","article-title":"Neuroprotective effects of psychotropic drugs in Huntington's disease","volume":"14","author":"Lauterbach","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2021.174432_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fnmol.2016.00084","article-title":"NF-\u03baB pathways in the pathogenesis of multiple sclerosis and the therapeutic implications","volume":"9","author":"Leibowitz","year":"2016","journal-title":"Front. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.ejphar.2021.174432_bib35","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.bcp.2008.07.017","article-title":"Activation of Nrf2-antioxidant signaling attenuates NF\u03baB-inflammatory response and elicits apoptosis","volume":"76","author":"Li","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2021.174432_bib36","article-title":"Trifluoperazine attenuates naloxone-precipitated symptoms in morphine-dependent rats and mice","author":"Liang","year":"1986","journal-title":"Chin. Pharmacol. Bull."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174432_bib37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00401-015-1452-x","article-title":"Cell type-specific Nrf2 expression in multiple sclerosis lesions","volume":"130","author":"Licht-Mayer","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"40","key":"10.1016\/j.ejphar.2021.174432_bib38","doi-asserted-by":"crossref","first-page":"11215","DOI":"10.1021\/acs.jafc.0c04604","article-title":"Cuprizone-induced demyelination in mouse hippocampus is alleviated by ketogenic diet","volume":"68","author":"Liu","year":"2020","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174432_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal transduction and targeted therapy"},{"issue":"2","key":"10.1016\/j.ejphar.2021.174432_bib40","first-page":"150","article-title":"Effect of trifluoperazine on carrageenan-induced acute inflammation in intact and adrenalectomized rats","volume":"1","author":"Mahmoodi","year":"2009","journal-title":"International journal of physiology, pathophysiology and pharmacology"},{"key":"10.1016\/j.ejphar.2021.174432_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2019.05.010","article-title":"Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination","volume":"129","author":"Mandolesi","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174432_bib42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/brainsci11020272","article-title":"Cuprizone-induced neurotoxicity in human neural cell lines is mediated by a reversible mitochondrial dysfunction: relevance for demyelination models","volume":"11","author":"Mart\u00ednez-Pinilla","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejphar.2021.174432_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172973","article-title":"Targeting Keap1\/Nrf2\/ARE signaling pathway in multiple sclerosis","volume":"873","author":"Michali\u010dkov\u00e1","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejphar.2021.174432_bib44","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","article-title":"The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase","volume":"247","author":"Misra","year":"1972","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174432_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejphar.2013.10.062","article-title":"Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease","volume":"723","author":"Molokie","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174432_bib46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11011-019-00488-z","article-title":"Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal model","volume":"35","author":"Nellessen","year":"2020","journal-title":"Metab. Brain Dis."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174432_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/1573406413666170906123857","article-title":"Is there a link between vitamin B and multiple sclerosis?","volume":"14","author":"Nemazannikova","year":"2018","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejphar.2021.174432_bib48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ddmod.2018.09.003","article-title":"Cuprizone as a model of myelin and axonal damage","volume":"25","author":"Nyamoya","year":"2017","journal-title":"Drug Discov. Today Dis. Model."},{"issue":"7","key":"10.1016\/j.ejphar.2021.174432_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02102","article-title":"Cuprizone toxicity and Garcinia kola biflavonoid complex activity on hippocampal morphology and neurobehaviour","volume":"5","author":"Omotoso","year":"2019","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.ejphar.2021.174432_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5115\/acb.2018.51.2.119","article-title":"Ameliorative effects of Moringa on cuprizone-induced memory decline in rat model of multiple sclerosis","volume":"51","author":"Omotoso","year":"2018","journal-title":"Anatomy & cell biology"},{"issue":"5","key":"10.1016\/j.ejphar.2021.174432_bib51","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2174\/187152712801661220","article-title":"Viruses and multiple sclerosis","volume":"11","author":"Oskari Virtanen","year":"2012","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"2","key":"10.1016\/j.ejphar.2021.174432_bib52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11064-006-9165-0","article-title":"The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia","volume":"32","author":"Pasquini","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2021.174432_bib53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","article-title":"Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis","volume":"47","author":"Praet","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174432_bib54","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/08923973.2019.1578973","article-title":"Agmatine ameliorates acetic acid-induced colitis in rats: involvement of nitrergic system","volume":"41","author":"Rashidian","year":"2019","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"10","key":"10.1016\/j.ejphar.2021.174432_bib55","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.3390\/cells9102187","article-title":"Aquaporin-4 expression during toxic and autoimmune demyelination","volume":"9","author":"Rohr","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2021.174432_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fnins.2021.591302","article-title":"Validation of computer-adaptive contrast sensitivity as a tool to assess visual impairment in multiple sclerosis patients","volume":"15","author":"Rosenkranz","year":"2021","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174432_bib57","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1080\/13880209.2017.1319867","article-title":"Neuroprotective effects of ellagic acid on cuprizone-induced acute demyelination through limitation of microgliosis, adjustment of CXCL12\/IL-17\/IL-11 axis and restriction of mature oligodendrocytes apoptosis","volume":"55","author":"Sanadgol","year":"2017","journal-title":"Pharmaceut. Biol."},{"issue":"11","key":"10.1016\/j.ejphar.2021.174432_bib58","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3390\/cells8111314","article-title":"Suppression of the peripheral immune system limits the central immune response following cuprizone-feeding: relevance to modelling multiple sclerosis","volume":"8","author":"Sen","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ejphar.2021.174432_bib59","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0006-2952(76)90393-2","article-title":"Influence of psychotropic drugs and \u03b2-diethylaminoethyl-diphenylpropylacetate (SKF 525-A) on mescaline-induced behavior and on tissue levels of mescaline in mice","volume":"25","author":"Shah","year":"1976","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174432_bib60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.intimp.2018.09.041","article-title":"Protective and therapeutic role of bilobalide in cuprizone-induced demyelination","volume":"66","author":"Sui","year":"2019","journal-title":"Int. Immunopharm."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174432_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2005.11.050","article-title":"Trifluoperazine, an orally available clinically used drug, disrupts opioid antinociceptive tolerance","volume":"397","author":"Tang","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"11","key":"10.1016\/j.ejphar.2021.174432_bib62","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1503\/cmaj.130727","article-title":"Drug therapy for multiple sclerosis","volume":"186","author":"Tavazzi","year":"2014","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2021.174432_bib63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2006.07.054","article-title":"Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine\/nitric oxide area of research","volume":"851","author":"Tsikas","year":"2007","journal-title":"J. Chromatogr. B"},{"issue":"7","key":"10.1016\/j.ejphar.2021.174432_bib64","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1007\/s12035-015-9404-y","article-title":"The effect of melatonin on behavioral, molecular, and histopathological changes in cuprizone model of demyelination","volume":"53","author":"Vakilzadeh","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174432_bib65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1570159X15666170717120343","article-title":"Five decades of cuprizone, an updated model to replicate demyelinating diseases","volume":"17","author":"Vega-Riquer","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174432_bib66","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cns.13154","article-title":"Retracted: effect of Fasudil on remyelination following cuprizone\u2010induced demyelination","volume":"26","author":"Wang","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2021.174432_bib67","article-title":"Vagus nerve stimulation ameliorates renal ischemia-reperfusion injury through inhibiting NF-\u03baB activation and iNOS protein expression","author":"Wang","year":"2020","journal-title":"Oxidative medicine and cellular longevity"},{"key":"10.1016\/j.ejphar.2021.174432_bib68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jmbbm.2017.04.017","article-title":"The mechanical importance of myelination in the central nervous system","volume":"76","author":"Weickenmeier","year":"2017","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.ejphar.2021.174432_bib69","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3389\/fphar.2019.01029","article-title":"Antipsychotic drug trifluoperazine suppresses colorectal cancer by inducing G0\/G1 arrest and apoptosis","volume":"10","author":"Xia","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174432_bib70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuint.2015.08.015","article-title":"The cuprizone-induced changes in 1H-MRS metabolites and oxidative parameters in C57BL\/6 mouse brain: effects of quetiapine","volume":"90","author":"Xuan","year":"2015","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.ejphar.2021.174432_bib71","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/WCO.0000000000000205","article-title":"Advances in the immunopathogenesis of multiple sclerosis","volume":"28","author":"Yadav","year":"2015","journal-title":"Curr. Opin. Neurol."},{"issue":"11","key":"10.1016\/j.ejphar.2021.174432_bib72","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/nu10111618","article-title":"The immunomodulatory and anti-inflammatory role of polyphenols","volume":"10","author":"Yahfoufi","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174432_bib73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cytogfr.2014.09.002","article-title":"An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders","volume":"26","author":"Yang","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"9","key":"10.1016\/j.ejphar.2021.174432_bib74","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4103\/1673-5374.237109","article-title":"Role of nuclear factor \u03baB in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"13","author":"Yue","year":"2018","journal-title":"Neural regeneration research"},{"issue":"6","key":"10.1016\/j.ejphar.2021.174432_bib75","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3390\/molecules22060883","article-title":"Identification of non-electrophilic Nrf2 activators from approved drugs","volume":"22","author":"Zhang","year":"2017","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.ejphar.2021.174432_bib76","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1039\/C6FO00825A","article-title":"Myricetin alleviates cuprizone-induced behavioral dysfunction and demyelination in mice by Nrf2 pathway","volume":"7","author":"Zhang","year":"2016","journal-title":"Food & function"},{"key":"10.1016\/j.ejphar.2021.174432_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00391","article-title":"Nuclear factor \u03baB (NF-\u03baB)\u2013Mediated inflammation in multiple sclerosis","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Immunol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921005859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921005859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:55:48Z","timestamp":1757976948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921005859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":77,"alternative-id":["S0014299921005859"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174432","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trifluoperazine reduces cuprizone-induced demyelination via targeting Nrf2 and IKB in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174432"}}